1991 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 1991: 34 approvals, 0 patent expiries, 0 Phase 3 milestones.

FDA / EMA / MHRA approvals (34)

• 1991-01-04 — Zofran · GSK (originally Glaxo) · United States · Gastroenterology
• 1991-10-31 — Biaxin · Generic (originally Abbott/AbbVie) · United States · Infectious Disease
• 1991-11-01 — Zithromax · Pfizer Inc. · United States · Infectious Disease
• 1991-12-30 — Zoloft · Pfizer Inc. · United States · Neuroscience
• 1992 — MELPHALAN HYDROCHLORIDE
• 1992 — HALOFANTRINE HYDROCHLORIDE
• 1992 — Shade Uvaguard · Bayer · Dermatology
• 1992 — Eabeth · Metabolic
• 1992 — Halfan · GSK · Rare Disease
• 1992 — Orthoclone Okt3 · Ortho Biotech · Immunology
• 1992 — Suprane · Baxter · Neuroscience
• 1992 — Manoplax · Cardiovascular
• 1992 — Shade Uvaguard · Bayer Healthcare Llc · Other
• 1992 — Mivacron · AbbVie · Neuroscience
• 1992 — Alocril · AbbVie · Immunology
• 1992 — Taxol · Pfizer · Oncology
• 1992 — Teflox · Infectious Disease
• 1992 — Mepron · Immunology
• 1992 — Ortho-Cept · Merck & Co. · Other
• 1992 — ITRACONAZOLE
• 1992 — PAROXETINE
• 1992 — Proleukin · Chiron · Oncology
• 1992 — TERBINAFINE HYDROCHLORIDE
• 1992 — Sporanox · Sebela Ireland Ltd · Oncology
• 1992 — Daypro · Solubiomix · Immunology
• 1992 — Zebeta · Teva · Cardiovascular
• 1992 — Taxol · Pfizer · Oncology
• 1992 — Sodium Thiosulfate · Us Army · Metabolic
• 1992 — Taxol · Pfizer · Oncology
• 1992 — Prohance · Bracco · Other
• 1992 — PACLITAXEL
• 1992 — Vantin · Metabolic
• 1992 — Actinex · Metabolic
• 1992 — Imitrex · GSK · Neuroscience

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.